3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole has been researched along with spiperone in 1 studies
| Studies (3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole) | Trials (3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole) | Recent Studies (post-2010) (3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole) | Studies (spiperone) | Trials (spiperone) | Recent Studies (post-2010) (spiperone) |
|---|---|---|---|---|---|
| 18 | 1 | 0 | 2,944 | 13 | 85 |
| Protein | Taxonomy | 3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole (IC50) | spiperone (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0008 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.097 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.0005 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.097 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.097 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0635 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.097 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0001 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohmaker, K; Friedhoff, AJ; Goldstein, M; Meller, E; Schweitzer, JW | 1 |
1 other study(ies) available for 3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole and spiperone
| Article | Year |
|---|---|
Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Topics: Animals; Apomorphine; Binding, Competitive; Corpus Striatum; Haloperidol; Indoles; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone | 1985 |